UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cytomegalovirus in Solid Organ Transplantation

American journal of transplantation, 2013-03, Vol.13 (s4), p.93-106

2013

Volltextzugriff (PDF)

An Interventional Study Using Cell‐Mediated Immunity to Personalize Therapy for Cytomegalovirus Infection After Transplantation

American journal of transplantation, 2017-09, Vol.17 (9), p.2468-2473

2017

Volltextzugriff (PDF)

CMV: Prevention, Diagnosis and Therapy

American journal of transplantation, 2013-02, Vol.13 (s3), p.24-40

Kotton, C. N.

2013

Volltextzugriff (PDF)

Cytomegalovirus in Solid Organ Transplant Recipients

American journal of transplantation, 2009-12, Vol.9, p.S78-S86

2009

Volltextzugriff (PDF)

New data on efficacy of valacyclovir in secondary prevention of maternal–fetal transmission of cytomegalovirus

Ultrasound in obstetrics & gynecology, 2023-01, Vol.61 (1), p.59-66

2023

Volltextzugriff (PDF)

Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation

American journal of transplantation, 2020-06, Vol.20 (6), p.1703-1711

2020

Volltextzugriff (PDF)

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients

American journal of transplantation, 2010-05, Vol.10 (5), p.1228-1237

2010

Volltextzugriff (PDF)

Cytomegalovirus mismatch still negatively affects patient and graft survival in the era of routine prophylactic and preemptive therapy: A paired kidney analysis

American journal of transplantation, 2019-02, Vol.19 (2), p.573-584

2019

Volltextzugriff (PDF)

Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real‐world experience

Transplant infectious disease, 2019-12, Vol.21 (6), p.e13187-n/a

2019

Volltextzugriff (PDF)

Universal newborn screening for congenital cytomegalovirus infection: feasibility and relevance in a French type‐III maternity cohort

BJOG : an international journal of obstetrics and gynaecology, 2022-01, Vol.129 (2), p.291-299

2022

Volltextzugriff (PDF)

Congenital cytomegalovirus infection in pregnancy: a review of prevalence, clinical features, diagnosis and prevention

Australian & New Zealand journal of obstetrics & gynaecology, 2016-02, Vol.56 (1), p.9-18

2016

Volltextzugriff (PDF)

Impact of breast milk‐acquired cytomegalovirus infection in premature infants: Pathogenesis, prevention, and clinical consequences?

Reviews in medical virology, 2020-11, Vol.30 (6), p.1-11

2020

Volltextzugriff (PDF)

Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses

American journal of transplantation, 2015-10, Vol.15 (10), p.2655-2664

2015

Volltextzugriff (PDF)

Functional Fc receptors are crucial in antibody‐mediated protection against cytomegalovirus

European journal of immunology, 2024-10, Vol.54 (10), p.e2451044-n/a

2024

Volltextzugriff (PDF)

Monitoring of CMV‐specific cell‐mediated immunity with a commercial ELISA‐based interferon‐γ release assay in kidney transplant recipients treated with antithymocyte globulin

American journal of transplantation, 2020-08, Vol.20 (8), p.2070-2080

2020

Volltextzugriff (PDF)

The up side of decidual natural killer cells: new developments in immunology of pregnancy

Immunology, 2014-04, Vol.141 (4), p.490-497

2014

Volltextzugriff (PDF)

Body surface area compared to body weight dosing of valganciclovir is associated with increased toxicity in pediatric solid organ transplantation recipients

American journal of transplantation, 2023-12, Vol.23 (12), p.1961-1971

2023

Volltextzugriff (PDF)

Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review

Reviews in medical virology, 2014-11, Vol.24 (6), p.420-433

2014

Volltextzugriff (PDF)

Antiviral toxicities in pediatric solid organ transplant recipients

American journal of transplantation, 2022-12, Vol.22 (12), p.3012-3020

2022

Volltextzugriff (PDF)

Letermovir prophylaxis reduced cytomegalovirus reactivation and resistance post umbilical cord blood transplantation

British journal of haematology, 2024-06, Vol.204 (6), p.2378-2389

2024

Volltextzugriff (PDF)

Cytomegalovirus transmission in mismatched solid organ transplant recipients: Are factors other than anti‐viral prophylaxis at play?

American journal of transplantation, 2021-12, Vol.21 (12), p.3958-3970

2021

Volltextzugriff (PDF)

Pretransplant Immediately Early‐1‐Specific T Cell Responses Provide Protection for CMV Infection After Kidney Transplantation

American journal of transplantation, 2013-07, Vol.13 (7), p.1793-1805

2013

Volltextzugriff (PDF)

Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

American journal of transplantation, 2007-09, Vol.7 (9), p.2106-2113

2007

Volltextzugriff (PDF)

Human cytomegalovirus seropositivity and its influence on oral rotavirus vaccine immunogenicity: a specific concern for HIV-exposed-uninfected infants

Clinical and experimental immunology, 2024-06, Vol.217 (1), p.99-108

2024

Volltextzugriff (PDF)

1 – 25 von 657

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieTransplantation Proceedings

KollektionWiley Online Library Full Collection 2018

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(655)
Mit Volltextzugriff
(625)

Publikationsform

Artikel
(657)

Sprache

Englisch
(657)

Erscheinungsjahr

n.n

Thema

Humans
(630)
Science & Technology
(561)
Life Sciences & Biomedicine
(560)
Cytomegalovirus Infections - Prevention & Control
(496)
Cytomegalovirus
(420)
Transplantation
(378)
Female
(365)
Male
(336)
Adult
(288)
Middle Aged
(267)
Antiviral Agents - Therapeutic Use
(236)
Surgery
(205)
Biological And Medical Sciences
(180)
Medical Sciences
(177)
Infectious Diseases
(171)
Retrospective Studies
(169)
Ganciclovir - Therapeutic Use
(145)
Prophylaxis
(145)
Risk Factors
(134)
Immunology
(130)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Cytomegalovirus in Solid Organ Transplantation

An Interventional Study Using Cell‐Mediated Immunity to Personalize Therapy for Cytomegalovirus Infection After Transplantation

CMV: Prevention, Diagnosis and Therapy

Cytomegalovirus in Solid Organ Transplant Recipients

New data on efficacy of valacyclovir in secondary prevention of maternal–fetal transmission of cytomegalovirus

Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients

Cytomegalovirus mismatch still negatively affects patient and graft survival in the era of routine prophylactic and preemptive therapy: A paired kidney analysis

Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real‐world experience

Universal newborn screening for congenital cytomegalovirus infection: feasibility and relevance in a French type‐III maternity cohort

Congenital cytomegalovirus infection in pregnancy: a review of prevalence, clinical features, diagnosis and prevention

Impact of breast milk‐acquired cytomegalovirus infection in premature infants: Pathogenesis, prevention, and clinical consequences?

Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses

Functional Fc receptors are crucial in antibody‐mediated protection against cytomegalovirus

Monitoring of CMV‐specific cell‐mediated immunity with a commercial ELISA‐based interferon‐γ release assay in kidney transplant recipients treated with antithymocyte globulin

The up side of decidual natural killer cells: new developments in immunology of pregnancy

Body surface area compared to body weight dosing of valganciclovir is associated with increased toxicity in pediatric solid organ transplantation recipients

Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021

Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review

Antiviral toxicities in pediatric solid organ transplant recipients

Letermovir prophylaxis reduced cytomegalovirus reactivation and resistance post umbilical cord blood transplantation

Cytomegalovirus transmission in mismatched solid organ transplant recipients: Are factors other than anti‐viral prophylaxis at play?

Pretransplant Immediately Early‐1‐Specific T Cell Responses Provide Protection for CMV Infection After Kidney Transplantation

Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

Human cytomegalovirus seropositivity and its influence on oral rotavirus vaccine immunogenicity: a specific concern for HIV-exposed-uninfected infants

Aktive Filter

Suchergebnisse filtern